The United States labour market delivered a confusing picture in July, as nonfarm payrolls unexpectedly declined while the unemployment rate simultaneously fell. The headline payroll figure showed a drop of 23,000 jobs,
The American Bar Association has sought detailed information regarding the Trump administration’s executive orders targeting major law firms, a development drawing significant legal scrutiny. The move by the ABA signals growing institutional
More
Vulcan Materials (VMC), one of the largest producers of construction aggregates in the United States, has been removed from the Russell 1000 Index. The Russell 1000 tracks the largest publicly traded companies
More
On June 29, 2026, the Equal Employment Opportunity Commission voted to rescind two key policy documents guiding voluntary affirmative action in American workplaces. The two documents removed were the EEOC’s “Affirmative Action
More
The Quacquarelli Symonds team at Top Universities has released its annual global law school rankings, giving lawyers and students a worldwide look at legal education. The methodology behind the rankings draws on
More
The FTSE 100 underperformed its European counterparts on Thursday, weighed down by a steep decline in pharmaceutical giant AstraZeneca (AZN.L). AstraZeneca shares tumbled 6.2%, shedding 886p to close at 13,354p, after the
More
Wall Street advanced as strong performances from chip stocks helped investors look past growing concerns over instability in the Middle East. The technology sector led the broader market higher, with semiconductor companies
More
City lawyer Ian Rosenblatt has filed a legal claim against music mogul Simon Cowell in London’s High Court over fees he alleges were wrongfully withheld. The lawsuit follows Rosenblatt’s departure as a
More
The California Supreme Court has moved to restrict the use of a legal provision that allowed parties to disqualify judges without judicial scrutiny of their claims. The ruling centres on California Code
More
AstraZeneca (AZN.L) has suffered a dramatic stock market collapse, shedding more than £20 billion in value after a major clinical trial setback. The FTSE 100 pharmaceutical giant’s shares plunged by as much
More
Ginkgo Bioworks Holdings (DNA) has seen its share price fall to US$9.07, a level that has drawn renewed attention to recent insider trading activity at the synthetic biology company. What makes the
More